Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Jade Biosciences (JBIO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 33,283,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aerovate Therapeutics is a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Co.'s initial focus is on improving AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 6,000 6,000 6,000 934,110
Total Buy Value $44,400 $44,400 $44,400 $1,594,344
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 2
Total Shares Sold 0 0 0 375,799
Total Sell Value $0 $0 $0 $8,510,104
Total People Sold 0 0 0 7
Total Sell Transactions 0 0 0 51
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 246
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Frohlich Tom Chief Executive Officer   •       •      –    2025-05-16 4 B $7.40 $44,400 D/D 6,000 6,000 0.01     -
   Harwin Peter Evan   –       •       •   2025-04-28 3 IO $0.00 $0 I/I 0 3,220,368     -
   King Andrew James See Remarks   •       –      –    2025-04-28 3 IO $0.00 $0 D/D 0 344,863     -
   Klein Lawrence Otto   –       •      –    2025-04-28 3 IO $0.00 $0 D/D 0 86,215     -
   Shah Rajeev M. 10% Owner   –       –       •   2025-04-28 4 A $0.00 $0 I/I 1,062,326 1,287,858     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-08-01 4 OE $1.74 $2,622 D/D 1,507 14,252     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-07-31 4 OE $1.74 $19,930 D/D 11,454 12,745     -
   Shah Rajeev M. Director   –       •       •   2024-06-17 4 B $1.67 $1,549,944 I/I 928,110 7,893,678 2.25     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-06-14 4 AS $25.00 $265,000 D/D (10,600) 0     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-06-14 4 OE $14.59 $154,654 D/D 10,600 10,600     -
   Eldridge George A SEE REMARKS   •       –      –    2024-06-14 4 AS $25.03 $375,450 D/D (15,000) 5,022     -
   Eldridge George A SEE REMARKS   •       –      –    2024-06-14 4 OE $2.14 $32,100 D/D 15,000 20,022     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-06-13 4 AS $24.50 $147,000 D/D (6,000) 5,602     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-06-13 4 OE $2.14 $12,840 D/D 6,000 11,602     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-05-17 4 AS $21.07 $84,332 D/D (4,000) 5,602     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-05-17 4 OE $2.14 $8,560 D/D 4,000 9,602     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-16 4 AS $21.52 $215,755 D/D (10,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-16 4 OE $2.14 $21,400 D/D 10,000 10,000     -
   Verwijs Marinus CHIEF TECHNICAL OFFICER   •       –      –    2024-05-02 4 S $21.02 $41,631 D/D (1,981) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-01 4 AS $19.91 $230,946 D/D (11,357) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2024-05-01 4 OE $2.14 $21,400 D/D 10,000 10,000     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-04-17 4 AS $22.30 $89,522 D/D (4,000) 3,251     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2024-04-17 4 OE $1.74 $6,960 D/D 4,000 7,251     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-17 4 AS $22.32 $153,327 D/D (6,853) 1,291     -
   Dake Benjamin T SEE REMARKS   •       –      –    2024-04-17 4 OE $2.14 $14,665 D/D 6,853 8,144     -
  246 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us